QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.105.097121v1 317/2/598    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abey, H. T. Articles by Cocks, T. M. Search for Related Content PubMed PubMed Citation Articles by Abey, H. T. Articles by Cocks, T. M.

INFLAMMATION AND IMMUNOPHARMACOLOGY

Protease-Activated Receptor-2 Peptides Activate Neurokinin-1 Receptors in the Mouse Isolated Trachea

Department of Pharmacology, University of Melbourne, Parkville, Australia (H.T.A., R.W.B., T.M.C.); Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia (D.P.F.); and Sackler Institute of Pulmonary Pharmacology, King's College, London, United Kingdom (J.D.M.)

Protective roles for protease-activated receptor-2 (PAR₂) in the airways including activation of epithelial chloride (Cl^–) secretion are based on the use of presumably PAR₂-selective peptide agonists. To determine whether PAR₂ peptide-activated Cl^– secretion from mouse tracheal epithelium is dependent on PAR₂, changes in ion conductance across the epithelium [short-circuit current (I_SC)] to PAR₂ peptides were measured in Ussing chambers under voltage clamp. In addition, epithelium- and endothelium-dependent relaxations to these peptides were measured in two established PAR₂ bioassays, isolated ring segments of mouse trachea and rat thoracic aorta, respectively. Apical application of the PAR₂ peptide SLIGRL caused increases in I_SC, which were inhibited by three structurally different neurokinin receptor-1 (NK₁R) antagonists and inhibitors of Cl^– channels but not by capsaicin, the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP_8–37, or the nonselective cyclooxygenase inhibitor indomethacin. Only high concentrations of trypsin caused an increase in I_SC but did not affect the responses to SLIGRL. Relaxations to SLIGRL in the trachea and aorta were unaffected by the NK₁R antagonist nolpitantium (SR 140333) but were abolished by trypsin desensitization. The rank order of potency for a range of peptides in the trachea I_SC assay was 2-furoyl-LIGRL > SLCGRL > SLIGRL = SLIGRT > LSIGRL compared with 2-furoyl-LIGRL > SLIGRL > SLIGRT > SLCGRL (LSIGRL inactive) in the aorta relaxation assay. In the mouse trachea, PAR₂ peptides activate both epithelial NK₁R coupled to Cl^– secretion and PAR₂ coupled to prostaglandin E₂-mediated smooth muscle relaxation. Such a potential lack of specificity of these commonly used peptides needs to be considered when roles for PAR₂ in airway function in health and disease are determined.

Address correspondence to: Dr. Thomas M. Cocks, Department of Pharmacology, The University of Melbourne, Victoria, 3010, Australia. E-mail: thomasmc{at}unimelb.edu.au

This article has been cited by other articles:

				M. Saifeddine, M. L. Seymour, Y.-P. Xiao, S. J. Compton, S. Houle, R. Ramachandran, W. K. MacNaughton, S. Simonet, C. Vayssettes-Courchay, T. J. Verbeuren, et al. Proteinase-activated receptor-2 activating peptides: distinct canine coronary artery receptor systems Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3279 - H3289. [Abstract] [Full Text] [PDF]

				D. A. Vesey, W. A. Kruger, P. Poronnik, G. C. Gobe, and D. W. Johnson Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1441 - F1449. [Abstract] [Full Text] [PDF]